Aadi clinches first FDA nod for ultrarare sarcoma drug Fyarronews2021-11-23T14:14:12+00:00November 23rd, 2021|Fierce Pharma|
BeiGene plans to spend ‘several hundred million dollars’ on initial build-out of landmark US sitenews2021-11-23T13:52:40+00:00November 23rd, 2021|Fierce Pharma|
CDMO Hovione to expand New Jersey manufacturing site, add 100 jobs as part of $170M growth pushnews2021-11-23T13:05:03+00:00November 23rd, 2021|Fierce Pharma|
Novartis may have a buyer for $21B generics unit Sandoz: reportnews2021-11-22T21:28:30+00:00November 22nd, 2021|Fierce Pharma|
GlaxoSmithKline takes aim at sick pay access inequities with microgrant program and new campaignnews2021-11-22T20:48:02+00:00November 22nd, 2021|Fierce Pharma|
ARIA side effects surface in 40% of patients on Biogen’s Alzheimer’s drug Aduhelm: JAMAnews2021-11-22T20:12:48+00:00November 22nd, 2021|Fierce Pharma|
Sagent Pharmaceuticals recalls injectable seizure med thanks to familiar packaging glitchnews2021-11-22T18:34:08+00:00November 22nd, 2021|Fierce Pharma|
EsoCap swallows up VC cash to fuel study of topical delivery to the esophagusnews2021-11-22T16:47:07+00:00November 22nd, 2021|Fierce Pharma|
Topical treatment for chemotherapy pain clears early clinical test, teeing up further study of alternative to oral optionsnews2021-11-22T16:41:20+00:00November 22nd, 2021|Fierce Pharma|
Amgen’s Otezla, Repatha and biosimilars put on notice, with challenging years aheadnews2021-11-22T16:19:02+00:00November 22nd, 2021|Fierce Pharma|
